CARGO Therapeutics Inc (NASDAQ:CRGX) has a beta value of -0.12 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $215.29M, closed the recent trade at $4.68 per share which meant it gained $0.08 on the day or 1.63% during that session. The CRGX stock price is -443.8% off its 52-week high price of $25.45 and 35.9% above the 52-week low of $3.00. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.97 million shares traded. The 3-month trading volume is 1.22 million shares.
The consensus among analysts is that CARGO Therapeutics Inc (CRGX) is Buy stock at the moment, with a recommendation rating of 3.29. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.57.
CARGO Therapeutics Inc (NASDAQ:CRGX) trade information
Sporting 1.63% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CRGX stock price touched $4.68 or saw a rise of 1.27%. Year-to-date, CARGO Therapeutics Inc shares have moved -67.58%, while the 5-day performance has seen it change 4.82%. Over the past 30 days, the shares of CARGO Therapeutics Inc (NASDAQ:CRGX) have changed 11.84%. Short interest in the company has seen 3.52 million shares shorted with days to cover at 4.55.
Wall Street analysts have a consensus price target for the stock at $7, which means that the shares’ value could jump 33.14% from the levels at last check today.. The projected low price target is $7.0 while the price target rests at a high of $7.0. In that case, then, we find that the latest price level in today’s session is -49.57% off the targeted high while a plunge would see the stock gain -49.57% from the levels at last check today..
CARGO Therapeutics Inc (CRGX) estimates and forecasts
The company’s shares have lost -78.46% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
Earnings growth for 2025 is a modest 34.06% while over the next 5 years, the company’s earnings are expected to increase by 9.69%.
CRGX Dividends
CARGO Therapeutics Inc is expected to release its next earnings report on 2025-Mar-11 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
CARGO Therapeutics Inc (NASDAQ:CRGX)’s Major holders
Insiders own 1.13% of the company shares, while shares held by institutions stand at 122.71% with a share float percentage of 124.12%. Investors are also buoyed by the number of investors in a company, with CARGO Therapeutics Inc having a total of 147.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 6.88 million shares worth more than $112.92 million. As of 2024-06-30, FMR LLC held 15.8659% of shares outstanding.
The other major institutional holder is SAMSARA BIOCAPITAL, LLC, with the holding of over 4.42 million shares as of 2024-06-30. The firm’s total holdings are worth over $72.51 million and represent 10.1875% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and T. Rowe Price Health Sciences Fund, Inc. . As of Dec 31, 2024 , the former fund manager holds about 2.59% shares in the company for having 1.19 shares of worth $5.57 million while later fund manager owns 1.14 shares of worth $5.33 million as of Dec 31, 2024 , which makes it owner of about 2.48% of company’s outstanding stock.
